Some biotech companies made impressive runs over the course of this past week. These select few stood out from the rest.
Evoke Pharma shares saw a handy gain on Wednesday following news of a positive meeting with the FDA over Gimoti.
Shares of Evoke Pharma rose in the market on Tuesday in the wake of solid draft guidance for its Phase 3 study.
Source: ThinkstockThe latter part of the week was difficult for the biotech and specialty pharmaceutical sector. Unsettling news out of Washington, D.C., on potential changes in the taxation of the...